What you need to know about the 'alarming' new XBB.1.5 COVID subvariant
![Blue gloves holding Moderna COVID-19 vaccine booster and syringe](https://cdn.mos.cms.futurecdn.net/PgbSCP2zgJ4kUjaDhdLGhZ-415-80.jpg)
A new COVID-19 Omicron subvariant is causing concern among scientists monitoring the virus's spread and evolution, CNN reports. On Friday, the Centers for Disease Control and Prevention's COVID-19 variant dashboard revealed startling data concerning a variant with features that could encourage a surge of COVID cases in the U.S. — XBB.1.5.
Throughout December, the CDC estimates that XBB.1.5 has more than doubled its share of positive COVID cases every week, leading it to rise from 4 percent to 41 percent of new infections by the end of the month. XBB.1.5 is responsible for 75 percent of new cases in the Northeast, per the CDC. Virologists and epidemiologists predict that the features of this Omicron variant could drive a surge of positive cases in the U.S. However, according to CNN, it remains to be seen how extensive or severe that wave could be.
Despite lingering concerns that China's ongoing surge following the unraveling of its zero COVID policy would pose a threat, experts say XBB.1.5 emerged in the U.S. According to GISAID, a global initiative to catalog and track variants of COVID, the subvariant was first detected in New York and Connecticut in late October. It's the product of two descendants of BA.2, the subvariant that drove a small surge in the U.S. in April.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A recent study found that the XBB sublineage had higher levels of immune evasion, making it exponentially less likely to be neutralized by antibodies in previously infected or vaccinated people. Scientists behind the study called the level of immune evasion "alarming," suggesting that it could be detrimental to the efficacy of COVID vaccines.
XBB.1.5 also has a genetic mutation that allows it to bind more tightly to ACE2, the entryway for viruses into human cells, meaning it is more infectious.
"The mutation is clearly letting XBB.1.5 spread better," Jesse Bloom, a computational virologist at the Fred Hutchinson Cancer Center who flagged the mutation, wrote in an email to CNN.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
10 recent scientific breakthroughs
In Depth From cell reparation to monkey communication
By Devika Rao, The Week US Published
-
TV to watch in September, from 'Agatha All Along' to 'The Penguin'
The Week Recommends A 'WandaVision' spinoff, a DC Comics villain's starring turn and a silly Netflix original
By Anya Jaremko-Greenwold, The Week US Published
-
Pope urges climate action, unity at Jakarta mosque
Speed Read The pope and the mosque's top cleric signed a joint declaration encouraging religious tolerance and climate change action
By Peter Weber, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published